Lv42
618 积分 2021-04-05 加入
Anti-drug Antibody Validation Testing and Reporting Harmonization Addendum
1天前
已完结
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
1天前
已完结
Prevalence of Chronic Kidney Disease in China
3天前
已完结
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria
3天前
已完结
The American Psychiatric Association Practice Guidelines for the Psychiatric Evaluation of Adults
6天前
已完结
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
7天前
已完结
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
7天前
已完结
Vunakizumab for Radiographic Axial Spondyloarthritis
9天前
已关闭
Prevalence of Elevated Lipoprotein(a) and its Association With Subclinical Atherosclerosis in 2.9 Million Chinese Adults
13天前
已完结
Diabetes in China: epidemiology, pathophysiology and multi-omics
13天前
已完结
皖公网安备34019202002308
